CoChat

Metformin treatment rescues CD8+ T-cell response to immune checkpoint inhibitor therapy in mice with NAFLD

Open access
Wabitsch, Simon, McCallen, Justin D., Kamenyeva, Olena, Ruf, Benjamin, McVey, John C., Kabat, Juraj, Walz, Juliane S., Rotman, Yaron, Bauer, Kylynda C., Craig, Amanda J., Pouzolles, Marie, Phadke, Ira, Catania, Vanessa, Green, Benjamin L., Fu, Claude, Diggs, Laurence P., Heinrich, Bernd, Wang, Xin Wei, Ma, Chi, Greten, Tim F. · 2022 · Journal of Hepatology
Cited by 143

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Background & Aims: Non-alcoholic steatohepatitis (NASH) represents the fastest growing underlying cause of hepatocellular carcinoma (HCC) and has been shown to impact immune effector cell function. The standard of care for the treatment of advanced HCC is immune checkpoint inhibitor (ICI) therapy, yet NASH may negatively affect the efficacy of ICI therapy in HCC. The immunologic mechanisms underlying the impact of NASH on ICI therapy remain unclear. Methods: Here, using multiple murine NASH models, we analyzed the influence of NASH on the CD8+ T cell-dependent anti-PD-1 responses against liver cancer. We characterized CD8+ T cells’ transcriptomic, functional, and motility changes in normal (ND) and NASH diet. Results: NASH blunted the effect of anti-PD-1 therapy against liver cancers in multiple murine models. NASH caused a proinflammatory phenotypic change of hepatic CD8+ T cells. Transcriptomic analysis revealed changes related to NASH-dependent impairment of hepatic CD8+ T cell metabolism. In vivo imaging analysis showed reduced motility of intra-tumoral CD8+ T cells. Metformin treatment rescued the efficacy of anti-PD-1 therapy against liver tumors in NASH. Conclusions: Our study discovered a critical regulation of CD8+ T cell metabolism in ICI therapy for liver cancer in the context of NASH, a finding with potential implications for treating liver cancer patients with NASH.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2022.03.010

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 143

Metadata

Authors
Wabitsch, S., McCallen, J. D., Kamenyeva, O., Ruf, B., McVey, J. C., Kabat, J., Walz, J. S., Rotman, Y., Bauer, K. C., Craig, A. J., Pouzolles, M., Phadke, I., Catania, V., Green, B. L., Fu, C., Diggs, L. P., Heinrich, B., Wang, X. W., Ma, C., & Greten, T. F.
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2022-09
Volume
77
Issue
3
Pages
748-760
ISSN
0168-8278 (ISSN-L)
OpenAlex
W4221049711
Cited by
143
References
17
FWCI
11.24
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.